Elastase inhibitors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 17, 2004
Grant Date -
May 22, 2003
app pub date -
Dec 20, 2000
filing date -
Jun 2, 1994
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
This invention relates to compounds which are inhibitors of elastase, particularly human neutrophil elastase. The inhibitors are short, synthetic peptides in which the P.sub.2 moiety is substituted with various nitrogen-containing heterocyclic groups. As inhibitors of human neutrophil elastase, the compounds are useful in the treatment of a patient afflicted with a neutrophil associated inflammatory disease.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully